Introduction
In spite of introduction of modern anti-epileptic drug (AED) therapy, state-of-the-art of epilepsy surgery, and vagus nerve stimulation (VNS), approximately 30% of patients continue to have refractory seizures.
1,2 Deep brain stimulation (DBS) via an implanted neuro-stimulator system has been recognized as a promising, alternative therapeutic choice for epilepsy. Among various neural targets for DBS, the anterior nucleus of thalamus (ATN) has been considered a good locus for seizure control. 3, 4 Very recently, the results of a randomized, double blind, multicenter trial (SANTE, Stimulation of the Anterior Nucleus of Thalamus for Epilepsy) were released showing favorable therapeutic efficacy on refractory partial or secondary generalized epilepsy. 5 Various adverse neuropsychological changes may occur after DBS surgery used to control movement disorders such as Parkinson's disease, essential tremor, or dystonia. 6 Therefore, a careful and meticulous neuropsychological (NP) testing has been a routine and indispensable procedure ahead of the surgical implantation to pre-empt serious post-surgical adverse effects. However, to the best of our knowledge, no previous report has examined the cognitive changes in detail after ATN DBS in patients with refractory epilepsy. The aim of this study was to investigate the long-term cognitive effects of bilateral ATN stimulation in patients with refractory epilepsy using a comprehensive NP testing.
Methods

Patients
Patients were enrolled for bilateral ATN DBS based on the following criteria: frequent (more than 4 per a month) and disabling seizures not controlled by multiple antiepileptic drugs (AEDs) treatment; not candidates for resective surgical treatment as determined by video-EEG monitoring (e.g. multifocal ictal onset zone); patients (or caregivers) agreed to keep a daily seizure diary for a 3-month baseline period before DBS implantation and continuously after initiation of treatment; patients (or caregivers) agreed that no changes to the baseline presurgical medication regimen would be made during at least the first year after DBS implantation. The study was approved by the institutional review board of Catholic University of Korea, and informed written consent was obtained from all patients or their family members.
From our initial series of fifteen patients who completed at least 1 year follow-up after implantation, 9 patients were included in this study (Table 1) . Six patients were excluded from these reasons: three with a considerable cognitive derangement from mental retardation (IQ < 70), not adequate for our comprehensive NP testing; the other 3 patients underwent only one session of NP assessment, two refused a participation in the follow-up examination, the other was not tested during the pre-operative period.
Procedures
The presurgical evaluations performed were video EEG monitoring, optimum 1.5-T MRI, SPECT, 18-FDG PET, and full neuropsychological assessment. All patients underwent the same NP testing with the implantable pulse generator (IPG) in the ON state at least 12 months after ATN DBS surgery. Stimulation parameter settings remained unchanged for at least 2 weeks before evaluation. Between the two time points, all patients were under the same or slightly adjusted antiepileptic drug (AED) dosage, and minimal change (less than 1 AED) was made in their pre-operative AED composition ( Table 2) . 
Statistical analysis
Continuous variables with a normal distribution were analyzed using paired t-tests to investigate differences between baseline and post-operation NP results. When continuous variables showed an asymmetric distribution, the Wilcoxon rank sum test was performed.
We also used linear regression models to further evaluate the relationship of long-term clinical outcome and neuro-cognitive changes to each of the twenty-seven domains of our NP testing. Statistical significance of all tests was evaluated at a significance level of 0.05. Statistical analyses were performed using SPSS 12.0 (SPSS, Inc., Chicago, IL).
Results
Demographic characteristics of patients
The age of patients at surgery ranged from 14 to 49 years. Four patients were male. The duration of epilepsy ranged from 8 to 39 years. All patients had experienced more than 2 years of postoperative follow-up, ranging from 22 to 60 months (mean 34.6 AE 16.6 months). Post-operative NP assessments were performed after more than 1 year (mean 15.9 AE 5.0 months) after the ATN DBS operation.
All nine patients had complex partial seizures evolving to secondary generalized seizures. Their ictal onsets were not lateralized or were multifocal (Table 1) . After long term followup, 7 (77.8%) of our patients experienced a significant reduction in their seizure frequency (>50% seizure reduction). The overall mean seizure-reduction rate of nine patients after ATN DBS was 57.9% (35.6-90.4%, Table 3 ).
Neuropsychological data
Results were favorable for the word fluency tasks (letter and category, p < 0.05), and a significant improvement was observed on the RKMT of delayed verbal memory (p = 0.017) after DBS procedures. There were no significant changes in general abilities (IQ, MMSE), information processing (digit forward and backward, Trail A, and Digit-Symbol Substitution), or executive function (Trail B, FAB, and WCST). Detailed neuropsychological testing results are described in Tables 4 and 5 .
Intriguingly, there was no statistically significant correlation between clinical effect after ATN DBS (seizure reduction rate) and the NP measurements; delayed verbal recall (r = 0.505, p = 0.17), Word Fluency Test (letter, r = À0.276, p = 0.47; category, r = À0.011, p = 0.98), as well as the other NP domains (verbal, performance and total IQ; short term, visual and total memory; various frontal lobe function tests including TMT-A and B, and WCST).
Discussion
ATN is a collection of deep nuclei thought to affect not only the modulation of alertness but also learning and memory. Prior clinical studies have shown that ATN dysfunction may be associated with deficits in declarative memory (semantic and episodic memory). 13 However, cognitive decline after chronic ATN DBS has not been noticed in some case studies. 3, 4 Only a brief and limited description on the general intelligence quotient (IQ) test results after ATN DBS was reported. 14 In SANTE trial, a subjective deterioration of memory function was reported in 13% of patients during the initial period (for 3 months after surgery). But it was neither serious in severity nor maintained chronically (all resolved over 12-476 days). 5 To our knowledge, we now provide the first long-term NP data concerning the full cognitive function of ATN DBS patients with intractable epilepsy. Our patients did not show any meaningful decline in various NP domains after chronic ATN stimulation. Moreover, word fluency and delayed verbal memory were significantly improved after the procedure. We can hypothesize several underlying mechanisms of the beneficial effects observed after ATN DBS on cognition besides its antiepileptic effects.
First, we assumed that electrical stimulation of ATN also directly activated the limbic memory circuit and the associated thalamo-cortical pathway, resulting in significant improvement in verbal memory or verbal fluency after chronic stimulation. This hypothesis is supported by some recent studies. Bilateral ATN stimulation of the rat brain reversibly increased glucose uptake in connected thalamic nuclei and both hippocampi, which might be attributed to excitation of efferent thalamohippocampal projections from the ATN. 15 A case study with long-term hypothalamic/fornix stimulation for controlling morbid obesity provided interesting data showing that hippocampus-dependent memory improvement originated from the activation of the hippocampal memory circuit through stimulation of the fornix. 16 In that case, the hypothalamic/fornix stimulation also induced some improvement of verbal fluency (phonemic and semantic). This may reflect a contributing role of the medial temporal regions not only to memory but also to language, due to their close interaction with neighboring neocortical structures specialized in language processing, 17 such as perirhinal cortex 18 in our ATN DBS patients.
Second, we can suppose that the improved cognitive function originated from decreased AED dosage or reduced seizure frequency. Four among our patients had been under topiramate (TPM), which is most likely to induce deficits in working memory, and verbal fluency. 19, 20 Minimal reduced dosage of TPM in one patient (400-300 mg per day, patient 2) was accompanied by supplementing the levetiracetam (LEV) for controlling her refractory seizures. LEV administration may have a favorable impact or even improvement in some of NP measures, such as attention, verbal fluency and memory functions. [21] [22] [23] But the minimal AED compositional change and dosage adjustment did not seem to have a great influence on the overall neuro-cognitive data we observed in this study (Tables 2 and 5 ), especially on patient 2 (whose delayed verbal recall and categorial word fluency did not improve after ATN DBS). Third, we could find that a good clinical outcome was not a univariate predictor of any of the NP domains. There was no difference in the NPT data obtained between our seven patients (patients 1, 3, 4, 6, 7, 8 and 9) , who achieved more than a 50% seizure reduction, and the other patients (patients 2 and 5) with 50% reduction (data not shown). Finally, we cannot exclude a practice effect from repeated NP assessment may not be excluded. However, practice is likely to have had a minimal or negligible effect on follow-up NP testing performed at least 1 year postsurgery.
In conclusion, the effects of bilateral ATN DBS on cognition shown here represent an interesting collateral effect in the context of antiepileptic treatment for intractable epilepsy. Clinical considerations regarding ATN DBS for treating refractory epilepsy are in the early stages, and additional convincing data of the chronic influence of DBS on the cognition or behavior will be forthcoming.
